Roche Holding, the Swiss pharmaceuticals group, managed to sell a huge $1bn (€1.2bn) convertible, despite continued insistence from equity-linked investors that they are full to bursting of new bonds.

The deal, which carried a contingency payment clause that has never been used on a European equity-linked bond before, was sold into a market that is rapidly shutting for summer.